@article {45841,
	title = {Leptin mediates the increase in blood pressure associated with obesity.},
	journal = {Cell},
	volume = {159},
	year = {2014},
	month = {2014 Dec 4},
	pages = {1404-16},
	abstract = {<p>Obesity is associated with increased blood pressure (BP), which in turn increases the risk of cardiovascular diseases. We found that the increase in leptin levels seen in diet-induced obesity (DIO) drives an increase in BP in rodents, an effect that was not seen in animals deficient in leptin or leptin receptors (LepR). Furthermore, humans with loss-of-function mutations in leptin and the LepR have low BP despite severe obesity. Leptin{\textquoteright}s effects on BP are mediated by neuronal circuits in the dorsomedial hypothalamus (DMH), as blocking leptin with a specific antibody, antagonist, or inhibition of the activity of LepR-expressing neurons in the DMH caused a rapid reduction of BP in DIO mice, independent of changes in weight. Re-expression of LepRs in the DMH of DIO LepR-deficient mice caused an increase in BP. These studies demonstrate that leptin couples changes in weight to changes in BP in mammalian species.</p>
},
	issn = {1097-4172},
	doi = {10.1016/j.cell.2014.10.058},
	author = {Simonds, Stephanie E and Pryor, Jack T and Ravussin, Eric and Greenway, Frank L and Dileone, Ralph and Allen, Andrew M and Bassi, Jaspreet and Elmquist, Joel K and Keogh, Julia M and Henning, Elana and Myers, Martin G and Licinio, Julio and Brown, Russell D and Enriori, Pablo J and O{\textquoteright}Rahilly, Stephen and Sternson, Scott M and Grove, Kevin L and Spanswick, David C and Farooqi, I Sadaf and Cowley, Michael A}
}
@article {4605,
	title = {Leptin targets in the mouse brain.},
	journal = {The Journal of Comparative Neurology},
	volume = {514},
	year = {2009},
	month = {2009 Jun 10},
	pages = {518-32},
	abstract = {<p>The central actions of leptin are essential for homeostatic control of adipose tissue mass, glucose metabolism, and many autonomic and neuroendocrine systems. In the brain, leptin acts on numerous different cell types via the long-form leptin receptor (LepRb) to elicit its effects. The precise identification of leptin{\textquoteright}s cellular targets is fundamental to understanding the mechanism of its pleiotropic central actions. We have systematically characterized LepRb distribution in the mouse brain using in situ hybridization in wildtype mice as well as by EYFP immunoreactivity in a novel LepRb-IRES-Cre EYFP reporter mouse line showing high levels of LepRb mRNA/EYFP coexpression. We found substantial LepRb mRNA and EYFP expression in hypothalamic and extrahypothalamic sites described before, including the dorsomedial nucleus of the hypothalamus, ventral premammillary nucleus, ventral tegmental area, parabrachial nucleus, and the dorsal vagal complex. Expression in insular cortex, lateral septal nucleus, medial preoptic area, rostral linear nucleus, and in the Edinger-Westphal nucleus was also observed and had been previously unreported. The LepRb-IRES-Cre reporter line was used to chemically characterize a population of leptin receptor-expressing neurons in the midbrain. Tyrosine hydroxylase and Cre reporter were found to be coexpressed in the ventral tegmental area and in other midbrain dopaminergic neurons. Lastly, the LepRb-IRES-Cre reporter line was used to map the extent of peripheral leptin sensing by central nervous system (CNS) LepRb neurons. Thus, we provide data supporting the use of the LepRb-IRES-Cre line for the assessment of the anatomic and functional characteristics of neurons expressing leptin receptor.</p>
},
	keywords = {Animals, Brain, Cell Count, Gene Expression, Immunohistochemistry, In Situ Hybridization, Lac Operon, Leptin, Male, Messenger, Mice, Photomicrography, Receptors, RNA, STAT3 Transcription Factor, Transgenic, Tyrosine 3-Monooxygenase},
	issn = {1096-9861},
	doi = {10.1002/cne.22025},
	author = {Scott, Michael M and Lachey, Jennifer L and Sternson, Scott M and Lee, Charlotte E and Elias, Carol F and Friedman, Jeffrey M and Elmquist, Joel K}
}
